Specifically, PHF10 expression was significantly correlated with immune subtypes in BLCA, STAD, LGG, BRCA, COAD, and KIRC (all p < 0.01, Figures 8B–G). The gene discussed is PHF10; the disease is bladder transitional cell carcinoma.